Zdrowie i gospodarka · 17/11/2017
Controlled Correspondence Related to Generic Drug Development; Draft Guidance for Industry; Availability; Correction
The Food and Drug Administration is correcting a notice entitled "Controlled Correspondence Related to Generic Drug Development; Draft Guidance for Industry; Availability" that appeared in the Federal Register of November 3, 2017. The document announced the availability of a draft guidance for industry. The document was published with the incorrect docket number. This document corrects that error.